Values for patient-measured morning peak expiratory flow rates ( PEFR ) were significantly ( P < .05 ) higher and the use of rescue albuterol was significantly ( P < .05 ) lower beginning 3 to 5 days after initiation of therapy in the groups treated with fluticasone propionate , compared with the placebo group .
